You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

target vessel failure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Native Coronary Artery Instead of SAphenous Vein Graft

Recruiting
  • Target Vessel Failure in Saphenous Vein Grafts
  • Percutaneous Coronary Intervention
  • Percutaneous coronary intervention of the native coronary artery with Synergy
  • Detroit, Michigan
  • +1 more
Jul 20, 2022

Vascular Diseases, Vascular System Injuries, End Stage Renal Disease on Dialysis Trial (Human Acellular Vessel (HAV))

Available
  • Vascular Diseases
  • +2 more
  • Human Acellular Vessel (HAV)
  • (no location specified)
Aug 17, 2022

Percutaneous Coronary Intervention, Coronary Artery Calcification, Coronary Artery Disease Trial in Denmark (Lithoplasty,

Recruiting
  • Percutaneous Coronary Intervention
  • +2 more
  • Lithoplasty
  • Conventional
  • Gentofte, Copenhagen, Denmark
  • +5 more
Oct 26, 2022

Respiratory Failure Trial in Nashville (Lower SpO2 Target, Intermediate SpO2 Target, Higher SpO2 Target)

Completed
  • Respiratory Failure
  • Lower SpO2 Target
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center
May 20, 2022

Complex Coronary Lesions Trial in Worldwide (IVUS, Angio)

Recruiting
  • Complex Coronary Lesions
  • IVUS
  • Angio
  • Aalst, Belgium
  • +31 more
Nov 24, 2022

The Implementation of Intravascular Ultrasound and Fractional

Completed
  • Coronary Artery Disease
  • FFR and IVUS guided PCI
  • Vilnius, Lithuania
    Vilnius University Hospital Santaros Klinikos
Nov 9, 2022

Oxygen Toxicity, Respiratory Failure Trial in Quebec (Manual Oxygen titration with Philips oximeter (SpO2 target 90%), Automated

Not yet recruiting
  • Oxygen Toxicity
  • Respiratory Failure
  • Manual Oxygen titration with Philips oximeter (SpO2 target 90%)
  • +3 more
  • Quebec, Canada
    Institut Universitaire de Cardiologie et de Pneumologie de Québe
Oct 18, 2022

Myocardial Infarction, Coronary Artery Bypass, Percutaneous Coronary Intervention Trial in Springfield, Detroit (RPE (usual

Not yet recruiting
  • Myocardial Infarction
  • +4 more
  • RPE (usual care)
  • GXT+THHR (intervention)
  • Springfield, Massachusetts
  • +1 more
Jun 22, 2023

Diagnostic Potential of UCHL1 in Acute Decompensated Heart

Recruiting
  • Heart Failure
  • Dyspnea; Cardiac
    • Columbia, South Carolina
      Wm. Jennings Bryan Dorn VA Medical Center, Columbia, SC
    Aug 11, 2022

    Left Heart Failure Trial in Nantong (Atrial shunt implant system)

    Recruiting
    • Left Heart Failure
    • Atrial shunt implant system
    • Nantong, Jiangsu, China
      Atrial shunt implant system
    Aug 1, 2022

    Hepatocellular Carcinoma Trial (Hepatic Artery Infusion Chemotherapy, Transarterial Chemoembolization, Regorafenib)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Hepatic Artery Infusion Chemotherapy
    • +3 more
    • (no location specified)
    Feb 7, 2022

    Acute Kidney Injury, Cirrhosis, Portal Hypertension Trial in San Francisco (MAP-Target Algorithm)

    Not yet recruiting
    • Acute Kidney Injury
    • +5 more
    • MAP-Target Algorithm
    • San Francisco, California
      University of California San Francisco
    Aug 14, 2023

    Persistent Pulmonary Hypertension of the Newborn, Hypoxemic Respiratory Failure Trial in Sacramento (95% - 99% SpO2 target)

    Enrolling by invitation
    • Persistent Pulmonary Hypertension of the Newborn
    • Hypoxemic Respiratory Failure
    • 95% - 99% SpO2 target
    • Sacramento, California
      University of California-Davis
    Jan 25, 2022

    Drug-eluting Stent, Coronary Artery Disease Trial in Suwon (Genoss® DES system, Genoss® Osfit system)

    Recruiting
    • Drug-eluting Stent
    • Coronary Artery Disease
    • Genoss® DES system, Genoss® Osfit system
    • Suwon, Korea, Republic of
      Ajou University Hospital
    Sep 27, 2023

    Coronary Artery Disease, Ischemic Heart Disease Trial in Suwon (Procedure: planed 2-stent strategy, Procedure: provisional

    Recruiting
    • Coronary Artery Disease
    • Ischemic Heart Disease
    • Procedure: planed 2-stent strategy
    • Procedure: provisional 1-stent plus DEB strategy
    • Suwon, Gyeonggi-do, Korea, Republic of
      St. Vincent's Hospital , the Catholic University
    Aug 17, 2023

    In-stent Restenosis Trial in Yongin (Genoss® DCB)

    Enrolling by invitation
    • In-stent Restenosis
    • Genoss® DCB
    • Yongin, Korea, Republic of
      Yongin Severance Hospital
    Dec 11, 2022

    End Stage Renal Disease (ESRD) Trial (HAV, AVF)

    Not yet recruiting
    • End Stage Renal Disease (ESRD)
    • HAV
    • AVF
    • (no location specified)
    Jun 8, 2023

    Coronary Heart Disease, Angioplasty, Balloon Trial in Xi'an (Drug-coated balloon, Drug-eluting stents)

    Active, not recruiting
    • Coronary Heart Disease
    • Angioplasty, Balloon
    • Drug-coated balloon
    • Drug-eluting stents
    • Xi'an, Shannxi, China
      Ling Tao
    Jun 29, 2023

    Heart Failure Trial in Lexington, Falls Church (CardioMEMS)

    Not yet recruiting
    • Heart Failure
    • CardioMEMS
    • Lexington, Kentucky
    • +1 more
    Feb 9, 2022

    Coronary Artery Disease Trial in Nanjing (Stenting)

    Recruiting
    • Coronary Artery Disease
    • Stenting
    • Nanjing, Jiangsu, China
      Nanjing First Hospital
    Mar 26, 2022

    Ischemic Heart Disease Trial in Seoul (Percutaneous coronary intervention)

    Completed
    • Ischemic Heart Disease
    • Percutaneous coronary intervention
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Oct 24, 2022

    Respiratory Failure Trial (Respiratory support a, Respiratory support b)

    Not yet recruiting
    • Respiratory Failure
    • Respiratory support a
    • Respiratory support b
    • (no location specified)
    Apr 24, 2023

    Coronary Heart Disease, Angioplasty, Balloon Trial in Xi'an

    Completed
    • Coronary Heart Disease
    • Angioplasty, Balloon
      • Xi'an, Shannxi, China
        Ling Tao
      Jul 20, 2022

      Coronary Artery Disease Trial in Washington (PCI with SELUTION SLR DCB, PCI with FDA approved "-limus" DES)

      Not yet recruiting
      • Coronary Artery Disease
      • PCI with SELUTION SLR DCB
      • PCI with FDA approved "-limus" DES
      • Washington, District of Columbia
        MedStar Washington Hospital Center
      Jul 7, 2023

      Coronary Vessels Trial in Korea, Republic of (PCI)

      Active, not recruiting
      • Coronary Vessels
      • PCI
      • Daegu, Korea, Republic of
      • +5 more
      Jan 16, 2022